Latest news with #RegulationA
Los Angeles Times
22-07-2025
- Business
- Los Angeles Times
In Case You Missed It: Dr. Patrick Soon-Shiong Discusses theLaunch of the Los Angeles Times Next Network on ‘The DailyShow with Jon Stewart'
During an appearance on 'The Daily Show with Jon Stewart,' Los Angeles Times owner Dr. Patrick Soon-Shiong announced the launch of the L.A. Times Next Network. The new diversified media company is designed to rebuild trust in media and give voice to all by combining verified information, emerging technologies, and community participation across news, culture, entertainment, sports, and civic engagement. The Network consists of five coordinated pillars: the Los Angeles Times; LAT Next, a curated creator platform; Nant Games, focused on esports and civic/scientific gaming; NantStudios Virtual Production, oKering real-time virtual production capabilities; and L.A. Times Studios, supporting streaming, live events, and forums. The initiative will also pursue a novel Reg A+ financing, led by the investment bank Digital OKering, to broaden public ownership and participation allowing the readers, supporters and fans of the Los Angeles Times to become shareholders. Dr. Patrick Soon-Shiong said: 'My family bought the L.A. Times to ensure a voice for the community and now have a path to return it to the people. With this opportunity, readers, community members, everyone, will be the media: direct democracy in action. There's been an erosion of faith in our institutions, and I look forward to sharing this journey with the public. The need to restore truth and trust in media and in our institutions is more important now more than any time in our country's history- L.A. Times Next Network will strive to be the platform and the voice of the people.' Mark Elenowitz, Managing Director of Digital Offering, commented: 'We helped pioneer Regulation A to open ownership to everyday investors, and L.A. Times Next Network exemplifies that spirit, to allow those who have been customers and supporters of this iconic brand to become shareholders and participate in the next chapter of growth. This platform aligns community equity with a diversified, tech-enabled media ecosystem built on credibility, engagement data, and scalable production innovation.' Interested in becoming a shareholder? Sign up for information from Los Angeles Times Next Network, Inc. at
Yahoo
30-06-2025
- Business
- Yahoo
I have $2,700 in extra retirement income. What should I do with this money?
Moneywise and Yahoo Finance LLC may earn commission or revenue through links in the content below. Before you retire, you want to make sure you have enough income to cover your spending needs. But, plenty of people hope to leave work with the ability to cover more than just the bare necessities. Thanks to Jeff Bezos, you can now become a landlord for as little as $100 — and no, you don't have to deal with tenants or fix freezers. Here's how I'm 49 years old and have nothing saved for retirement — what should I do? Don't panic. Here are 4 of the easiest ways you can catch up (and fast) You don't have to be a millionaire to gain access to this $1B private real estate fund. In fact, you can get started with as little as $10 — here's how Let's say you happen to be a few years out from retirement, and are on track to have an extra $2,700 a month after covering the basics. Well, that's a pretty good financial position to be in. Annually, that would amount to $32,400 for life after paying the bills. So, what should you do with this "extra" money if you're lucky enough to have it? Here are a few possible options to consider. One of the first things you can do with that extra cash is invest it, so that you're putting it to work in the background. That way, the $2,700 a month can turn into even more. If you've already maxed out your 401(k) and you're looking for new assets to invest in, you might consider alternatives like gold or art. Opting for a gold IRA gives you the opportunity to hedge against market volatility by allowing you to invest directly in physical precious metals rather than stocks and bonds. If you'd like to convert an existing IRA into a gold IRA, companies typically offer 100% free rollover. Others might offer free gold, silver or other metals up to a certain amount when you make a qualifying purchase. You can check out the Moneywise list of industry-leading companies offering gold IRAs here. Compare offers instantly and request a free information guide to help you understand how to diversify your portfolio and secure your retirement fund. As for investing in art, that's the type of investment that used to require having a billionaire's checkbook. Now, anyone can invest in blue-chip artwork worth millions through Masterworks' art investing platform. Masterworks has already distributed back $60+ million in total proceeds (including principal) to investors across their 23 exits, posting a profitable return from selling a Basquiat painting for $8 million in 2024. See important Regulation A disclosures at Beyond investing, you can use surplus cash to give back to causes that resonate with you. 78% of pre-retirees and retirees between the ages of 50 and 80 indicated to Fidelity that they are committed to donating, and expect it to play a significant role in their retirement. Giving some of your extra money to causes that you care about can allow you to make a real difference in your later years. A financial advisor can also help you explore tax-efficient strategies for giving, as 21% of retirees aren't aware of any tax-advantaged methods of donating. is a free service that helps you find a financial advisor near you. They can help co-create a plan to reach your financial goals, based on your tax circumstances, by matching you with a small list of the best options for you to choose from. From their database of thousands, you get a pre-screened financial advisor you can trust. You can then set up a free, no-obligation consultation to make sure they're the right fit for you. Investing for your kids or grandkids is also a solid way to park your extra retirement money, as you can play an active role in helping the next generation get a head start on financial security. College costs are seeing significant increases. A four-year degree in the 2035-2036 academic year could run as high as $230,176 for a four-year period. If you want to spare your grandkids the burden of substantial student loans, you could look into funneling some of your extra money into a 529 plan. Read more: This tiny hot Costco item has skyrocketed 74% in price in under 2 years — but now the retail giant is restricting purchases. Typically, common financial wisdom dictates that you shouldn't succumb to lifestyle inflation (where your spending increases alongside your income). But, while this is prudent advice throughout much of your working years, if you now find yourself in a position to reap the benefits of smart financial moves or simple good luck, you could also use your extra funds to enjoy your life. You can begin by asking yourself what would personally bring you joy? You may decide you want to travel more or spend more time on your hobbies, as you aren't forced to work into your later years or you can let yourself enjoy dining out at nicer restaurants. Just be sure you don't go overboard, that you maintain a safe withdrawal rate, and maintain an emergency fund for any incidentals or unforeseen health expenses, even if you feel flush with cash for now. If you have a lot of cash sitting in your checking account, consider moving it to a high-yield savings account so you can get more bang for your buck. Financial aid only funds about 27% of US college expenses — but savvy parents are using this 3-minute move to cover 100% of those costs Elon Musk just endorsed Warren Buffett's '5-minute' fix for America's multi-trillion debt problem — and 1 Senator is drafting a constitutional change to make it real. Do you think it'll work? Rich, young Americans are ditching the stormy stock market — here are the alternative assets they're banking on instead Here's how much the average 60-year-old American has in retirement savings — and 5 critical ways you can secure your nest egg Stay in the know. Join 200,000+ readers and get the best of Moneywise sent straight to your inbox every week for free. This article provides information only and should not be construed as advice. It is provided without warranty of any kind.
Int'l Business Times
13-06-2025
- Business
- Int'l Business Times
Med-X: Pioneering Sustainable Pest Control on a Global Scale
A revolutionary shift in pest control is occurring, and it's being facilitated by the use of plant-based solutions. With an eye toward sustainable living and healthier choices, Matthew Mills, CEO and founder of Med-X, Inc., is leading the way for change in a modern world with the use of his Nature-Cide product line. The Genesis of Green Innovation An experienced entrepreneur, Mills is challenging the status quo, demonstrating that effective pest management can be achieved without compromising environmental sustainability. What began as a plan to address domestic needs as a local pest control service in Los Angeles California in the United States, has rapidly evolved into a global movement, inspiring widespread adoption of eco-conscious practices, which launched the brand Nature-Cide. "Everyone is our audience, as everyone wants to lead a healthier life," Mills explains. A Response to a Changing World Driven by an increasing demand for safer alternatives, Mills has used his company development experience to gather a team to create and advance the Nature-Cide brand of professional strength products, which aims to replace harmful chemical pesticides in both residential and commercial settings. Nature-Cide has rapidly achieved global recognition as a leading industrial-strength, natural pest control solution, emerging at a critical time when public skepticism towards conventional chemical products is on the rise. This sentiment was significantly amplified by the COVID-19 pandemic era, which heightened awareness of potential health and environmental hazards. This timing was pivotal, allowing Med-X to position itself as a trusted alternative amidst rapidly growing concerns. The Architect of Innovation Matthew Mills positioned a team with a wealth of experience to Med-X. Notably, his past accomplishments include spearheading the growth of a dot-com company to a value of $600 million while also being instrumental in its NASDAQ listing. Now, he is channeling his experience into propelling Med-X to new heights, including a newly launched $10 million Regulation A+ public offering supported by a substantial group of investors from around the world. Beyond "Greenwashing" Nature-Cide stands apart from some of the competitors who engage in "greenwashing," a type of deceitful marketing that aims to persuade the public that an organization's products or policies are environmentally friendly, when in fact they are not. The Nature-Cide brand delivers true professional-grade, plant-based alternatives that are trusted by industry applicators. And its transparency has been important in establishing Nature-Cide's credibility and driving its global acceptance. Med-X Inc. A Shift toward Conscious Living Med-X has ambitious plans for strategic expansion, which include the acquisition of complementary eco-focused businesses. This approach aims to solidify its position as a leading authority in the sustainable pest control sector and beyond. "We started Med-X to position Nature-Cide and Thermal-Aid as national brands, not realizing that Nature-Cide would garner interest worldwide. We are raising capital to position the company with the proper requirements to list on the NASDAQ, specifically growing the Company's Net Tangible assets". The company's growth is further supported by broader cultural and market shifts. Global trends emphasizing transparency and health-conscious lifestyles resonate deeply with Med-X's core values. This alignment has created a fertile ground for substantial international growth and expansion of Nature-Cide products. Shaping the Future of Pest Control Matthew Mills envisions Med-X as more than just a business; he sees it as an influential entity with the potential to drive significant change. He aims to utilize Med-X to influence policy, shape consumer behaviors, and redefine the established norms not only in pest control but across multiple industries. This long-term vision positions Med-X as a catalyst for a more sustainable and a health-conscious future.
Yahoo
05-06-2025
- Business
- Yahoo
Cabbacis Receives SEC Notice of Qualification for Regulation A Offering
Investors Can Now Subscribe to Purchase Common Shares in Cabbacis at $2.00 per Share NIAGARA FALLS, N.Y., June 05, 2025--(BUSINESS WIRE)--Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco-product manufacturer focused on harm-reduction products being developed under the iBlend™ brand name, confirmed that on June 3rd the U.S. Securities and Exchange Commission (SEC) qualified the Company's Offering Statement on Form 1-A for a Regulation A (Tier 2) offering. Cabbacis seeks to raise up to $7 million, minus professional expenses and any underwriter fees, through the public sale of its common stock at $2.00 per share. The Regulation A offering is open to broad participation by both accredited and non-accredited investors; the latter subject to applicable Regulation A investment limits. Access to the offering is available via where the Offering Circular and Subscription Agreement are publicly accessible. The Company will use the proceeds from the offering for product development and commercialization expenses, including FDA costs related to filing premarket tobacco product applications (PMTAs) for the U.S. market, tobacco and hemp plantings, general corporate purposes and potential acquisitions. About Cabbacis Cabbacis is committed to commercializing reduced-nicotine cigarettes and vaporizer pods. Both types of products in development are predominately tobacco and include hemp. The Company also plans to move forward with reduced-nicotine tobacco cigarettes (and little cigars) without hemp. Reduced-nicotine cigarettes without hemp have been evaluated in dozens of independent studies and contain about 95 percent less nicotine than conventional cigarettes. Results demonstrate, as reviewed in Donny and White 2022, that subjects smoked fewer cigarettes per day, reduced their nicotine dependence and exposure, doubled their quit attempts, and/or increased their number of smoke-free days. The Company believes including hemp flower into reduced-nicotine cigarettes improves product acceptability and may potentially improve effectiveness due to the presence of non-THC cannabinoids. The worldwide patent portfolio of Cabbacis LLC includes 35 issued patents and various pending patent applications across the United States, Europe, China, India, Japan, Indonesia, Russia, South Korea, Canada, Australia, New Zealand, Mexico, Brazil and other countries – where approximately two-thirds of the world's smokers reside. Cabbacis holds 7 U.S. patents. Cabbacis LLC is a wholly-owned subsidiary of Cabbacis Inc. To learn more about Cabbacis, please visit Cautionary Note Regarding Forward-Looking Statements This press release includes forward-looking statements within the meaning of the federal securities law. All statements other than statements of historical or current facts made in this document are forward-looking. We identify forward-looking statements in this document by using words or phrases such as "anticipate," "believe," "consider," "continue," "could," "estimate," "expect," "foresee," "intend," "likely," "may," "objective," "potential," "plan," "predict," "project," "seek," "should," "will" and similar words or phrases and their negatives. Forward-looking statements reflect our current expectations and are inherently uncertain. Actual outcomes or results could differ materially for a variety of reasons. Factors that could cause actual results to differ materially are described in "Risk Factors" in our Regulation A Offering Circular filed with the SEC and in our Annual Report on Form 1-K for the period ended December 31, 2024 filed with the SEC. We undertake no responsibility to publicly update or revise any forward-looking statement except as required by applicable law. This press release does not constitute an offer to sell or the solicitation of an offer to buy the Company's securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of that state or jurisdiction. View source version on Contacts Media Contact Deborah Agugliasupport@
Business Wire
05-06-2025
- Business
- Business Wire
Cabbacis Receives SEC Notice of Qualification for Regulation A Offering
NIAGARA FALLS, N.Y.--(BUSINESS WIRE)--Cabbacis (OTCQB: CABI), a U.S. federally-licensed tobacco-product manufacturer focused on harm-reduction products being developed under the iBlend™ brand name, confirmed that on June 3rd the U.S. Securities and Exchange Commission (SEC) qualified the Company's Offering Statement on Form 1-A for a Regulation A (Tier 2) offering. Cabbacis (OTCQB: CABI), a tobacco-product manufacturer, confirmed on June 3rd the SEC qualified the Company's Offering Statement: See Share Cabbacis seeks to raise up to $7 million, minus professional expenses and any underwriter fees, through the public sale of its common stock at $2.00 per share. The Regulation A offering is open to broad participation by both accredited and non-accredited investors; the latter subject to applicable Regulation A investment limits. Access to the offering is available via where the Offering Circular and Subscription Agreement are publicly accessible. The Company will use the proceeds from the offering for product development and commercialization expenses, including FDA costs related to filing premarket tobacco product applications (PMTAs) for the U.S. market, tobacco and hemp plantings, general corporate purposes and potential acquisitions. About Cabbacis Cabbacis is committed to commercializing reduced-nicotine cigarettes and vaporizer pods. Both types of products in development are predominately tobacco and include hemp. The Company also plans to move forward with reduced-nicotine tobacco cigarettes (and little cigars) without hemp. Reduced-nicotine cigarettes without hemp have been evaluated in dozens of independent studies and contain about 95 percent less nicotine than conventional cigarettes. Results demonstrate, as reviewed in Donny and White 2022, that subjects smoked fewer cigarettes per day, reduced their nicotine dependence and exposure, doubled their quit attempts, and/or increased their number of smoke-free days. The Company believes including hemp flower into reduced-nicotine cigarettes improves product acceptability and may potentially improve effectiveness due to the presence of non-THC cannabinoids. The worldwide patent portfolio of Cabbacis LLC includes 35 issued patents and various pending patent applications across the United States, Europe, China, India, Japan, Indonesia, Russia, South Korea, Canada, Australia, New Zealand, Mexico, Brazil and other countries – where approximately two-thirds of the world's smokers reside. Cabbacis holds 7 U.S. patents. Cabbacis LLC is a wholly-owned subsidiary of Cabbacis Inc. To learn more about Cabbacis, please visit Cautionary Note Regarding Forward-Looking Statements This press release includes forward-looking statements within the meaning of the federal securities law. All statements other than statements of historical or current facts made in this document are forward-looking. We identify forward-looking statements in this document by using words or phrases such as "anticipate," "believe," 'consider,' "continue," "could," "estimate," "expect," 'foresee,' "intend," 'likely,' "may," "objective," "potential," "plan," "predict," "project," "seek," 'should,' "will" and similar words or phrases and their negatives. Forward-looking statements reflect our current expectations and are inherently uncertain. Actual outcomes or results could differ materially for a variety of reasons. Factors that could cause actual results to differ materially are described in 'Risk Factors' in our Regulation A Offering Circular filed with the SEC and in our Annual Report on Form 1-K for the period ended December 31, 2024 filed with the SEC. We undertake no responsibility to publicly update or revise any forward-looking statement except as required by applicable law. This press release does not constitute an offer to sell or the solicitation of an offer to buy the Company's securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to qualification or registration under the securities laws of that state or jurisdiction.
